Electromed, Inc. to Participate in the Canaccord Genuity 45th Annual Growth Conference

Audio By Carbonatix

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Jul 29, 2025--

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Company management will participate in the Canaccord Genuity 45 th Annual Growth Conference, which will be held August 12-14, 2025 in Boston, MA. Electromed President and Chief Executive Officer Jim Cunniff, and Chief Financial Officer Brad Nagel will present on Tuesday, August 12 at 12:30 pm ET. Interested parties may access a live webcast of the presentation using the following link: Electromed CG Presentation. The link will also be posted on the Electromed Investor Relations website under Events & Presentations.

Institutional investors may request one-on-one meetings through Canaccord Genuity.

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest ® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250729970386/en/

CONTACT: Brad Nagel, Chief Financial Officer

(952) 758-9299

[email protected] Cavanaugh, Investor Relations

ICR Healthcare

(617) 877-9641

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA MINNESOTA MASSACHUSETTS

INDUSTRY KEYWORD: GENERAL HEALTH MEDICAL DEVICES HEALTH HEALTH TECHNOLOGY MEDICAL SUPPLIES

SOURCE: Electromed, Inc.

Copyright Business Wire 2025.

PUB: 07/29/2025 08:30 AM/DISC: 07/29/2025 08:32 AM

http://www.businesswire.com/news/home/20250729970386/en